Andy Liang

Andy Liang serves as an Adjunct Senior Lecturer at Monash University's Monash Suzhou Research Institute and Australian Regenerative Medicine Institute, conducting active research in neuroscience and pharmacology with emphasis on neurodegenerative diseases and stroke mechanisms.

His academic credentials include:

• PhD in Anatomy, University of New South Wales (2012)
• Master of Pathology, Fudan University (2006)
• Bachelor of Clinical Medicine, Shandong First Medical University (2003)

Dr. Liang's research centers on Alzheimer's disease pathogenesis through pericyte biology, neural circuit mapping for cognitive disorders and depression, and complementary medicine applications for stroke treatment. His work uniquely integrates traditional Chinese medicine with modern neuroscience, focusing on vascular mechanisms in neurodegeneration and nanoparticle-based drug delivery systems for neurological conditions. Current projects involve chemogenetic/optogenetic circuit mapping and pericyte-targeted therapies using transgenic mouse models.

Recent publications demonstrate multidisciplinary convergence across medical imaging, neuropharmacology, and cancer theranostics, with increasing emphasis on gut-brain axis interactions in cognitive disorders and ultrasound-mediated biomaterial delivery systems. This reflects a strategic shift toward translational applications of neural circuit research.

He received the Young Investigator Award in 2016 and has secured funding from the National Natural Science Foundation of China, Australian Research Council, and industry partners.

• Young Investigator Award (2016)

Dr. Liang actively supervises graduate research on Alzheimer's disease mechanisms and stroke therapeutics while serving as Section Editor for Science Progress and Guest Editor for Frontiers in Pharmacology. His laboratory work combines behavioral testing, molecular analysis, and advanced imaging techniques within collaborative frameworks spanning Australian and Chinese institutions.